117 related articles for article (PubMed ID: 12132779)
21. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
22. Cervical samples dried on filter paper and dried vaginal tampons can be useful to investigate the circulation of high-risk HPV in Congo.
Alidjinou EK; Ebatetou-Ataboho E; Sané F; Moukassa D; Dewilde A; Hober D
J Clin Virol; 2013 Jun; 57(2):161-4. PubMed ID: 23478164
[TBL] [Abstract][Full Text] [Related]
23. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus status in cervical scrapes and biopsy specimens using the HPV genotyping DNA microarray.
Son S; Noh HT; An S
Int J Gynaecol Obstet; 2006 Jun; 93(3):258-9. PubMed ID: 16687142
[No Abstract] [Full Text] [Related]
25. A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytologically normal smears.
Jacobs MV; Zielinski D; Meijer CJ; Pol RP; Voorhorst FJ; de Schipper FA; Runsink AP; Snijders PJ; Walboomers JM
Br J Cancer; 2000 Apr; 82(8):1421-6. PubMed ID: 10780521
[TBL] [Abstract][Full Text] [Related]
26. [Investigation of HPV-DNA in cervical smear samples by two different methods: MY09/11 consensus PCR and type-specific real-time PCR].
Sahiner F; Gümral R; Sener K; Yiğit N; Dede M; Yapar M; Kubar A
Mikrobiyol Bul; 2012 Oct; 46(4):624-36. PubMed ID: 23188576
[TBL] [Abstract][Full Text] [Related]
27. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
[TBL] [Abstract][Full Text] [Related]
28. Role of HPV testing in clinical practice.
Cuzick J
Virus Res; 2002 Nov; 89(2):263-9. PubMed ID: 12445665
[No Abstract] [Full Text] [Related]
29. DNA-EIA to detect high and low risk HPV genotypes in cervical lesions with E6/E7 primer mediated multiplex PCR.
Clavel C; Rihet S; Masure M; Chypre C; Boulanger JC; Quereux C; Birembaut P
J Clin Pathol; 1998 Jan; 51(1):38-43. PubMed ID: 9577370
[TBL] [Abstract][Full Text] [Related]
30. Can self vaginal douching for high risk HPV screening replace or assist efficacy of cervical cancer screening?
Suwannarurk K; Bhamarapravatana K; Kheolamai P; Thaweekul Y; Mairaing K; Poomtavorn Y; Pattaraarchachai J
Asian Pac J Cancer Prev; 2010; 11(5):1397-401. PubMed ID: 21198300
[TBL] [Abstract][Full Text] [Related]
31. Detection of HPV 16 and HPV 18 infection in patients with cervical neoplasia.
Karaloglu D; Yazici H; Alatli C; Yaman F; Aslay I; Onat H; Dalay N
Eur J Gynaecol Oncol; 1996; 17(4):296-8. PubMed ID: 8856310
[TBL] [Abstract][Full Text] [Related]
32. Cervical cancer screening from Pap smear to human papillomavirus DNA testing.
Jin XW; Xu H
Compr Ther; 2001; 27(3):202-8. PubMed ID: 11569320
[TBL] [Abstract][Full Text] [Related]
33. Role of HPV-assay as an adjuvant to Pap's smear for diagnosis of carcinoma cervix.
Shahi SK; Ranga S; Srivastava R
Indian J Pathol Microbiol; 2000 Oct; 43(4):383-5. PubMed ID: 11344599
[No Abstract] [Full Text] [Related]
34. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
35. A general primer pair for amplification and detection of genital human papillomavirus types.
Evander M; Wadell G
J Virol Methods; 1991; 31(2-3):239-50. PubMed ID: 1650785
[TBL] [Abstract][Full Text] [Related]
36. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
Othman N; Othman NH
Asian Pac J Cancer Prev; 2014; 15(5):2245-9. PubMed ID: 24716964
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus and cervical neoplasia.
Einstein MH; Goldberg GL
Cancer Invest; 2002; 20(7-8):1080-5. PubMed ID: 12449741
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens.
Cope JU; Hildesheim A; Schiffman MH; Manos MM; Lörincz AT; Burk RD; Glass AG; Greer C; Buckland J; Helgesen K; Scott DR; Sherman ME; Kurman RJ; Liaw KL
J Clin Microbiol; 1997 Sep; 35(9):2262-5. PubMed ID: 9276398
[TBL] [Abstract][Full Text] [Related]
39. A polymerase chain reaction-enzyme-linked immunosorbent assay method for detecting human papillomavirus in cervical carcinomas and high-grade cervical cancer precursors.
Lungu O; Sun XW; Wright TC; Ferenczy A; Richart RM; Silverstein S
Obstet Gynecol; 1995 Mar; 85(3):337-42. PubMed ID: 7862368
[TBL] [Abstract][Full Text] [Related]
40. Use of the same archival papanicolanou smears for detection of human papillomavirus by cytology and polymerase chain reaction.
McDonald RL; Rose BR; Gibbins J; Baird PJ
Diagn Mol Pathol; 1999 Mar; 8(1):20-5. PubMed ID: 10408789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
